R Zhou, H Ma, Y Liu, X Chen, X Chang… - Experimental …, 2022 - journals.sagepub.com
Despite significant advances in targeted and immune therapy for non-small cell lung cancer
(NSCLC), effective therapies for wild-type epidermal growth factor receptor/anaplastic …